US Patent Issued to HANGZHOU GLUBIO PHARMACEUTICAL on July 7 for "Isoindolinone compounds, and uses thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,936, issued on July 7, was assigned to HANGZHOU GLUBIO PHARMACEUTICAL Co. LTD. (Hangzhou, China).

"Isoindolinone compounds, and uses thereof" was invented by Liqiang Fu (Shanghai), Linglong Kong (Shanghai) and Yifeng Xia (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Isoindolinone compounds represented by the structural formula (I) or pharmaceutically-acceptable salts thereof can be used for the treatment of a proliferative disorder. Pharmaceutical compositions contain the isoindolinone compound or a salt thereof, and a pharmaceutically acceptable carrier."

The patent was filed on June 6, 2022, under Application No. 18/568,744.

*For furt...